Clinical trial
Selumetinib in Combination With Gefitinib in NSCLC Patients
NCT02025114
Study timeline
Study start (actual)2014-09-01Date precision: month
Registry last updated2018-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancer (NSCLC)unresolved
Interventions
selumetinibDRUG · verified · RxNorm: selumetinib
Sponsors & collaborators
National Taiwan University Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02025114 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.